Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,586
Total Claims
$913K
Drug Cost
816
Beneficiaries
$1,119
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,124 General Surgery providers
-85%
Opioid rate vs peers
4.6% vs 30.2% avg
+343%
Cost per patient vs peers
$1,119 vs $253 avg
+118%
Brand preference vs peers
10.9% vs 5.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
4.6%
Opioid Rate
487
Opioid Claims
$8,689
Opioid Cost
2.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,135 claims · $694K
Generic: 9,302 claims · $209K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 113 | $116K |
| Sitagliptin Phosphate | 59 | $66K |
| Dulaglutide | 44 | $57K |
| Liraglutide | 16 | $43K |
| Semaglutide | 28 | $42K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $36K |
| Ergotamine Tartrate/Caffeine | 11 | $36K |
| Insulin Detemir | 11 | $22K |
| Insulin Lispro | 26 | $20K |
| Lipase/Protease/Amylase | 12 | $20K |
| Fluticasone/Umeclidin/Vilanter | 24 | $17K |
| Mirabegron | 30 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $13K |
| Ticagrelor | 15 | $10K |
| Pramlintide Acetate | 13 | $9,498 |
Prescribing Profile
Patient Profile
77
Avg Age
56%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About